Tranzyme Pharma's Successful Phase 2 Postoperative Ileus Trial Results to be Presented at the American Society of ... (Business Wire via Yahoo! Finance)
RESEARCH TRIANGLE PARK, N.C.----Tranzyme Pharma today announced that Anthony J. Senagore, MD, MBA, MS, FACS, Vice President, Research & Education of Spectrum Health and Professor of Surgery, Michigan State University/CHM, will present results from the successful study of ghrelin agonist TZP-101 for the management of postoperative ileus at the upcoming 2009 Annual Meeting of the American Society ...
Read More.. and DISCUSS
RESEARCH TRIANGLE PARK, N.C.----Tranzyme Pharma today announced that Anthony J. Senagore, MD, MBA, MS, FACS, Vice President, Research & Education of Spectrum Health and Professor of Surgery, Michigan State University/CHM, will present results from the successful study of ghrelin agonist TZP-101 for the management of postoperative ileus at the upcoming 2009 Annual Meeting of the American Society ...
Read More.. and DISCUSS